Ayasha Williams-sharron, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1160 Varnum St Ne, Depaul Bldg., Suite 212, Washington, DC 20017 Phone: 202-507-8444 Fax: 202-507-8503 |
Michele Martin Johnson, MD Pain Medicine - Interventional Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 920 Varnum St Ne, Washington, DC 20017 Phone: 202-854-7400 |
Dr. John Francis Dombrowski, Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 New Mexico Ave Nw Ste 346nw, Washington, DC 20016 Phone: 202-362-4787 Fax: 202-365-4252 |
Chiemeka Onyima, M.D. Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2150 Pennsylvania Ave Nw, Washington, DC 20037 Phone: 202-741-3000 |
News Archive
In most cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, a toxin released by cells that normally nurture neurons in the brain and spinal cord can trigger loss of the nerve cells affected in the disease, Columbia researchers reported today in the online edition of the journal Neuron.
Researchers at the University of Pennsylvania School of Medicine have located the "skeleton key," a gene that, when damaged, causes the body's skeletal muscles and soft connective tissue to undergo a metamorphosis into bone, progressively locking joints in place and rendering movement impossible.
Eating healthy and being active are important, but choosing a healthy snack, planning a nutritious meal or checking the nutrition label on an item are not always easy for people with limited knowledge and resources. Two University of Missouri Extension programs are teaching families throughout the state how to make healthy choices to improve the quality of their lives.
Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs like aspirin have lower incidences of certain types of cancer. Now, in a study appearing in Cancer Cell on June 15, investigators at Sanford-Burnham Medical Research Institute and their colleagues have figured out how one NSAID, called Sulindac, inhibits tumor growth.
The process for producing what has become known as "pink slime" actually seemed like a triumph of technology in an industry haunted by the specter of food poisoning and, at one point, even got rave reviews in the news media, according to an article in the current issue of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
› Verified 3 days ago